fenta sl 800 sublingual tablets
rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 800 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.
fenta sl 133 sublingual tablets
rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 133 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.
fenta sl 133 sublingual tablets
rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 133 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.
fenta sl 67 sublingual tablets
rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 67 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.
fenta sl 67 sublingual tablets
rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 67 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.
jorveza 1 mg
rafa laboratories ltd - budesonide - tablets orodispersible - budesonide 1 mg - budesonide - treatment of eosinophilic esophagitis (eoe) in adults.
remodulin 10 mgml
rafa laboratories ltd - treprostinil as sodium - solution for injection - treprostinil as sodium 10 mg/ml - treprostinil - remodulin is indicated as a continuous subcutaneous infusion or intravenous infusion for the treatment of primary pulmonary arterial hypertension and pulmonary arterial hypertension associated with connective tissue disorders. pulmonary hypertension associated with congenital systemic to pulmonary shunts.
kalgaron orange
rafa laboratories ltd - cetylpyridinium chloride; lidocaine hydrochloride ( as monohydrate) - lozenges - cetylpyridinium chloride 1.25 mg; lidocaine hydrochloride ( as monohydrate) 1 mg - lidocaine - for the relief of severe sore throat. relief of mouth and throat infections.
kalgaron mint
rafa laboratories ltd - cetylpyridinium chloride; lidocaine hydrochloride ( as monohydrate) - lozenges - cetylpyridinium chloride 1.25 mg; lidocaine hydrochloride ( as monohydrate) 1 mg - lidocaine - for the relief of severe sore throat. relief of mouth and throat infections.
kalgaron strawbery
rafa laboratories ltd - cetylpyridinium chloride; lidocaine hydrochloride ( as monohydrate) - lozenges - cetylpyridinium chloride 1.25 mg; lidocaine hydrochloride ( as monohydrate) 1 mg - lidocaine - for the relief of severe sore throat. relief of mouth and throat infections.